Interferon therapy in primary care

Keyphrases

• Primary Care 100%
• Interferon-α (IFN-α) 100%
• Interferon Therapy 100%
• Viral Infection 40%
• Autoimmune Disease 20%
• During Pregnancy 20%
• Therapeutic Use 20%
• Host Defense 20%
• Life-threatening 20%
• Malignancy 20%
• Immune System 20%
• Maternal Outcomes 20%
• Neonatal Outcome 20%
• High-risk Human Papillomavirus (HR-HPV) 20%
• Skin Lesions 20%
• Chronic Granulomatous Disease 20%
• Early Pregnancy 20%
• Skin Condition 20%
• Keloid 20%
• Acute Renal Failure 20%
• Thrombotic Thrombocytopenic Purpura 20%
• Relapsing-remitting multiple Sclerosis 20%
• Human Blood Cells 20%
• Severe Adverse Effects 20%
• Host Modulation 20%
• Myeloproliferative Neoplasms 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Interferon 100%
• Virus Infection 20%
• Autoimmune Disease 10%
• Therapeutic Use 10%
• Human Papillomavirus 10%
• Multiple Sclerosis 10%
• Skin Defect 10%
• Acute Kidney Failure 10%
• Flu Like Syndrome 10%
• Keloid 10%
• Chronic Granulomatous Disease 10%
• Myeloproliferative Disorder 10%
• Thrombotic Thrombocytopenic Purpura 10%
• Side Effect 10%